The Kenilworth Plant is 30 MW combined-cycle, cogeneration project that serves the research and development complex of Merck & Co, Inc. Atlantic Power indirectly owns 100% of the project which commenced commercial operation in 1989. The electricity and steam produced by the facility are sold to Merck under an energy services agreement (ESA) that expired in 2012. The existng ESA has been extended on a month-to-month basis while a replacement ESA is being negotiated. The facility supplies additional steam to Merck from an onsite boiler house which includes four fas-fired boilers.
Atlantic Power operates and manages the project.
Kenilworth joined Atlantic Power through our acquisition of Capital Power Income LP in November 2011.